IPA has entered a strategic partnership with Ribopro aiming to transform therapeutic antibody discovery and development.

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a global leader in AI-powered antibody discovery and ...

Tardigrades, microscopic organisms renowned for their extraordinary resistance to radiation, may offer a means to protect ...

Drawing inspiration from the tardigrade, researchers developed a new strategy that may protect cancer patients from the side effects of radiation therapy.

About 60 percent of all cancer patients in the United States receive radiation therapy as part of their treatment.